18
Participants
Start Date
May 14, 2025
Primary Completion Date
November 5, 2025
Study Completion Date
November 5, 2025
ENA-001
Concentration for ENA-001 IV formulation is 10 mg/mL. Concentration for ENA 001 IM formulation is 30 mg/mL.
Placebo Comparator
Placebo comes in 5 mL/vial. Placebo matches ENA-001 injection; however, no ENA-001 is included.
RECRUITING
Dr. Vince Clinical Research, Overland Park
Lead Sponsor
National Institute on Drug Abuse (NIDA)
NIH
Enalare Therapeutics Inc.
INDUSTRY